JPMorgan Chase & Co’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Sell |
11,643
-32,149
| -73% | -$358K | ﹤0.01% | 4681 |
|
|
2025
Q1 | $538K | Sell |
43,792
-21,034
| -32% | -$259K | ﹤0.01% | 3966 |
|
|
2024
Q4 | $725K | Buy |
64,826
+52,829
| +440% | +$591K | ﹤0.01% | 3975 |
|
|
2024
Q3 | $83.6K | Buy |
11,997
+6,181
| +106% | +$43.1K | ﹤0.01% | 4791 |
|
|
2024
Q2 | $44K | Sell |
5,816
-26,299
| -82% | -$199K | ﹤0.01% | 4944 |
|
|
2024
Q1 | $424K | Buy |
32,115
+20,755
| +183% | +$274K | ﹤0.01% | 4050 |
|
|
2023
Q4 | $117K | Buy |
+11,360
| New | +$117K | ﹤0.01% | 4698 |
|
|
2022
Q2 | – | Sell |
-3,330
| Closed | -$27K | – | 5797 |
|
|
2022
Q1 | $27K | Sell |
3,330
-1,622
| -33% | -$13.2K | ﹤0.01% | 5208 |
|
|
2021
Q4 | $50K | Buy |
4,952
+2,278
| +85% | +$23K | ﹤0.01% | 5070 |
|
|
2021
Q3 | $42K | Sell |
2,674
-5,319
| -67% | -$83.5K | ﹤0.01% | 4997 |
|
|
2021
Q2 | $191K | Buy |
+7,993
| New | +$191K | ﹤0.01% | 4520 |
|